ATEMPT 2.0: Adjuvant T-DM1 vs TH
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rak piersi na wczesnym etapie (Stadium I) z dodatnim wynikiem na HER2, potwierdzony badaniem histologicznym
- •Brak przerzutów w węzłach chłonnych (N0) lub bardzo małe przerzuty (N1mic) zgodnie z klasyfikacją AJCC
- •HER2-dodatni potwierdzony przez centralną laboratorium (NeoGenomics) zgodnie z wytycznymi ASCO CAP 2018
- •Wykonane badania ER/PR (oznaczenie receptorów hormonalnych)
- •Nowotwory po obu stronach piersi lub wieloogniskowe są dopuszczalne, jeśli spełniają pozostałe kryteria
- •Wiek co najmniej 18 lat, niezależnie od statusu menopauzalnego
- •Stan ogólny pacjenta 0 lub 1 w skali ECOG
- •Upłynęło nie więcej niż 90 dni od ostatniej operacji piersi do planowanego rozpoczęcia leczenia
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- April 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (53)
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, United States
Smilow Cancer Hospital Care center at Derby
Derby, United States
Smilow Cancer Hospital Care center at Fairfield
Fairfield, United States
Smilow Cancer Hospital Care center at Glastonbury
Glastonbury, United States
Smilow Cancer Hospital Care center at Greenwich
Greenwich, United States
Smilow Cancer Hospital Care center at Guilford
Guilford, United States
Smilow Cancer Hospital Care center at St. Francis
Hartford, United States
Smilow Cancer Hospital Care center at Long Ridge
Long Ridge, United States
Yale Cancer Center at Yale University School of Medicine
New Haven, United States
Smilow Cancer Hospital Care center at North Haven
North Haven, United States
Stamford Hospital
Stamford, United States
Smilow Cancer Hospital Care center at Torrington
Torrington, United States
Smilow Cancer Hospital Care center at Trumbull
Trumbull, United States
Smilow Cancer Hospital Care center at Waterbury
Waterbury, United States
Smilow Cancer Hospital Care center at Waterford
Waterford, United States
Miami Cancer Institute/Baptist Hospital of Miami
Miami, United States
Miami Cancer Institute - Plantation (MCIP)
Plantation, United States
The University of Chicago Medical Center
Chicago, United States
Indiana University Health Joe & Shelly Schwarz Cancer Center
Carmel, United States
IU Health North Hospital
Carmel, United States
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, United States
Indiana University Sidney and Lois Eskenazi Hospital
Indianapolis, United States
Eastern Maine Medical Center (Northern Light)
Brewer, United States
New England Cancer Specialists
Scarborough, United States
Beth Israel Deaconess Medical Center
Boston, United States
Dana Farber Cancer Institute
Boston, United States
Massachusetts General Hospital
Boston, United States
Dana-Farber at St. Elizabeth's Medical Center
Brighton, United States
Lahey Clinic
Burlington, United States
Mass General North Shore Cancer Center
Danvers, United States
Dana-Farber Brigham Cancer Center - Foxborough
Foxborough, United States
Dana-Farber Cancer Instiute - Merrimack Valley
Methuen, United States
Dana-Farber at Milford
Milford, United States
Newton Wellesley Hospital
Newton, United States
Berkshire Medical Center
Pittsfield, United States
Dana Farber at South Shore Hospital
Weymouth, United States
NH Oncology-Hematology, PA - Payson Center for Cancer Care
Concord, United States
Dana-Farber Cancer Insitute at Londonderry Hospital
Londonderry, United States
Solinsky Center for Cancer Care (NH Oncology-Hematology, PA)
Manchester, United States
New England Cancer Specialists - Portsmouth
Portsmouth, United States
New York University Langone Hospital -Brooklyn
Brooklyn, United States
New York University Langone Hospital - Long Island
Mineola, United States
New York University Langone Health
New York, United States
Northwell University
New York, United States
Duke University Medical Center
Durham, United States
Duke Women's Cancer Care Raleigh
Raleigh, United States
Stefanie Spielman Comprehensive Breast Center
Columbus, United States
University of Pennsylvania, Abramson Cancer Center
Philadelphia, United States
University of Pittsburgh Medical Center Cancer UPMC- Magee Women's Hospital
Pittsburgh, United States
Smilow Cancer Hospital Care center at Westerly
Westerly, United States
Greco-Hainsworth Centers for Research/Tennessee Oncology
Nashville, United States
SCRI Oncology Partners
Nashville, United States
MD Anderson Cancer Center
Houston, United States
Trial contact
Sara Tolaney, MD, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.